Results for tag: "Mepixanox"

Mepixanox is a class of respiratory drugs used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. It is a type of bronchodilator, which works by relaxing the muscles in the airways, allowing more air to flow through them. Mepixanox is available in both short-acting and long-acting formulations, and is often used in combination with other medications. It is also used to prevent exercise-induced bronchospasm. The Mepixanox market is highly competitive, with a number of major pharmaceutical companies offering products. These include GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Other companies, such as AstraZeneca, Boehringer Ingelheim, and Teva Pharmaceuticals, also offer Mepixanox products. Show Less Read more